There is accumulating evidence that some biochemical pathways observ able by magnetic resonance spectroscopy, e.g., citrate acid and phospholipid metabolism, are altered in human prostate cancer. Four well-established human prostate cancer cell lines were therefore studied with magnetic resonance spectroscopy to compare differences in metabolic content with tumor biological behavior, Herein we demonstrate that, although each cell line has its own metabolic profile, relative creatine and citrate levels can be used to discriminate the androgen-dependent LNCaP cell line from the androgen-independent DU-145, TSU, and PC-3 cell lines*
INTRO DUCTIO N
The recent development and clinical introduction of transrectal probes not only improved the quality of magnetic resonance imaging (MRI) of the human prostate but also made this organ accessible to mag netic resonance spectroscopy (MRS) [ However, interpretations of differences in MRS spectra between human prostate tissues with differ ent biological behavior are hampered by tissue het erogeneity and the lack of a complete understanding of biochemical pathways. MRS examinations of welldefined human model systems are therefore needed to allow correlations between metabolic patterns and biological behavior. For this reason, studies of human prostate (cancer) cell strains are of value. Yacoe et al.
[17] investigated cell strains derived from human prostates to investigate whether 1H MRS could reli ably distinguish normal prostate epithelium from prostate cancer.17 In the present study w e attempted to identify differences in metabolites which correlated with different biological behavior, e.g., androgen re sponsiveness and morphology, in human prostate cancer. Four well-established human prostate cancer 
PSAproducing
cell lines were characterized with in vitro proton MRS, and metabolic differences were correlated with their biological behavior.
MATERIALS A N D METHODS

Tumor Cell Lines
Four established human prostatic carcinoma cell lines, PC-3, DU-145, TSU-Prl, and LNCaP, were used in this study, [18] [19] [20] [21] . The characteristics of the four cell lines are summarized in Table I . Cells were maintained in RPMI 1640 culture medium (Life Sci ence, Breda, The Netherlands) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 IU/ml penicillin, 100 (JLg/m l streptomycin, and 250 nM dexamethasone at 37°C in 6% C 0 2 at 99% relative hu midity.
Preparation of Tissue Extracts
After reaching a confluency of 70-80%, cells were harvested for perchloric acid (PCA) extraction as de scribed previously [14], In short, single-cell suspen sions were obtained by trypsinization (0.25% trypsin/ 0.1% EDTA) and immediately washed three times with ice cold 0.9% NaCl to remove all medium com ponents. The total number of cells varied between 4 -6 X 106 cells. Viability, as determined by the try pan blue dye exclusion test, was always ^95%. After centrifugation of the single-cell suspension, the cell pellet was frozen in liquid nitrogen and stored at -80°C until time of extraction.
The cell pellet was transferred into an all-glass homogenizer, and 4 ml ice-cold 0.25 M PCA were added dropwise. Cell homogenization was achieved at -80°C in approximately 30 min. After centrifugation (12,000 g, 15 min, 4°C) of the cell extract, the pellet was discarded and the pH of the supernatant was immediately adjusted to 7.5 with 2.5 M KOH. The PCA precipitate was centrifuged (12,000 g, 15 min, 4°C), and the supernatant was passed through a Chelex sample preparation disc (Bio-Rad Laboraties, Richmond, VA) and lyophilized. Lyophilizates were dissolved in 500 \ú 40 mM potassiumphosphate, pH 7.0. The pH was corrected to pH 6.90-7.10 if neces sary by addition of HC1 or KOH. The samples were lyophilizated again and stored at -20°C.
Three-ml samples of culture media of all prostate cancer cell lines investigated were lyophilizated and stored at -20°C, Just before the lH MRS measurements, the lyophüizate was carefully thawed and dissolved in 500 |xl D20 containing 1.6 mM 3-(trimethylsilyl) propi onic acid-d4 sodium salt (TSP).
*H NMR Measurements
2H NMR spectra were acquired on a 500 MHz spec trometer (Bruker AM500) and were recorded with a standard 5 mm aH NMR probe. The spectra were recorded employing a 45° flip angle (6 fjis) and a 7. 
RESULTS
PCA-Extracted Cell Lines
MR spectra of PCA extracts of four human prostate cancer cell lines were recorded, and for each cell line at least five different passages were investigated. A 500 MHz proton MR spectrum of a PCA extract of the LNCaP cell line, with two expanded parts, is shown in Figure 1 . Resonances of some main metabolites could be identified with data from the literature [14, 2 2 ].
For each compound, the best resolved reso nance^) were selected for quantitation purposes. Ta ble II lists relative peak area integral ratios involving the doublet of the CH3 group of lactate (Lac) at 1.33 ppm, the doublet of the CH3 group of alanine (Ala) at 1.49 ppm, the quartet of the CH2 group of citrate (Cit) at 2.54 ppm, the singlet of the CH3 group of (phospho)creatine at 3.04/3.05 ppm, singlets of the CH3 groups of phosphocholine (PC) and choline (Choi) at 3.23 and 3.22 ppm respectively, the triplet of the CH2 group of taurine (Tau) at 3.42 ppm, the sin glet of the CH2 group of glycine (Gly) at 3.59 ppm, and the triplet of the CH group of inositol (Ino) at 3.63 ppm.
Several differences were found among MRS spec tra of the PCA-extracted human cell lines.
The first prominent observation was of the rela tively high amount of total creatine (TCr = PCr + Cr) in the PCA extracts of LNCaP cells (Table II) . The TCr/TPS ratio was significantly higher for the LNCaP cells samples when compared with the other three cell lines (P < 0.01).
Secondly, citrate resonances were absent in the MR spectra of PCA extracts of the PC-3, DU-145, and TSU cell lines, whereas in only one of the five sam ples of the LNCaP cell line could citrate be detected in the MR spectra. Since citrate can rapidly diffuse from the prostate cell into the culture media, all media were also spectroscopically examined. 2H MR spectra of the culture media of the LNCaP cells show ed cit rate resonances, whereas in all the media of the other three cell lines no citrate resonances were detected (Kg. 2).
Finally, several differences in metabolic content of PCA extracts of DU-145, TSU, and PC-3 cells were found. The relative amount of taurine was signifi cantly higher for the DU-145 PCA cell extracts when compared with the PC-3 and TSU cell extracts (all P<0.01). PC-3 and TSU cell extracts differed signifi cantly from each other for inositol and creatine con tent, whereas the creatine content of DU-145 PCA extracts was also different from that of TSU PCA ex tracts (P<0.01, Table II ). be made [15] . A correlation of increased PCr concen tration and hormone sensitivity has also been sug gested for rat breast cancer [25] . Creatine levels can presently be detected in 1H MR spectra recorded with transrectal probes; hence, in vivo human MRS stud ie s can now test the relevance of these in vitro obser vations [26] .
Previous biochemical and MRS studies have sug gested that the metabolism of citrate may be altered in prostate cancer [12-14,27-30]. Citrate is a secretory product of the prostate, and its production and se cretion are under androgenic control [28] . Testoster one stimulates the net citrate production and might also play an role in citrate secretion [28] . Normally citrate is present in human prostate tissue in high concentrations [27, 28, 30] . In culture, however, citrate can rapidly diffuse from the prostate cell in the cul ture media [27] . It is therefore obligatory to measure both citrate levels in prostate ( In conclusion, this MRS study of PCA extracts of four human prostate cancer cell lines demonstrates that, although each cell line has its own metabolic fingerprint, the total creatine/tsp and citrate/tsp ratios can be used to discriminate the androgen-dependent LNCaP cell line from the other androgen-indepen dent cell lines. The extrapolation of these findings to the clinic will not be so easy. Clinical MRS studies with transrectal probes are ongoing, but are compli cated by several difficulties. The minimum volumes (voxels) within the prostate which can be measured with transrectal MRS are relatively large. Heteroge neity of the measured lesion, i.e., contamination of the cancer with normal prostate tissue and/or BPH, cannot be excluded. Smaller volumes and spectro scopic imaging methods will probably solve these problems. Secondly, a proper absolute quantification of the metabolites measured with in vivo MRS is still not possible.
The question remains as to whether MRS will be clinically applicable in the detection and staging of prostate cancer. Our results suggest that MRS might possibly play a role in the identification of hormoneresponsive prostate cancers.
